IPO's and Secondaries overview for the weeks of 2/6 - 2/17:
| Company | Symbol | Price | Shares | Trade Date | Underwriter(s) | Co-Manager(s) |
| CVR Partners, LP | UAN | $12.00-$14.00 | 19.2 million | 4/8 | Morgan Stanley, Barclays Capital, Goldman Sachs | Dahlman Rose & Co., RBS, Simmons & Co., Suntrust Robinson Humphrey |
| Golar LNG Partners LP | GMLP | $20.00-$22.00 | 12 million | 4/8 | Citi, BofA Merrill Lynch, Morgan Stanley | Raymond James, RBC Capital Markets, Wells Fargo Securities, BNP Paribas, DnB Markets, Evercore Partners |
| OCZ Technology Group | OCZ | Last trade $7.69 | 9.7 million | 4/8 | Stifel Nicholaus Weisel, Needham & Company | Craig-Hallum Capital, Merriman Capital |
| SandRidge Mississippian Trust I | SDT | $19.00-$21.00 | 12.5 million | 4/8 | Raymond James, Morgan Stanley, Wells Fargo Securities, RBC Capital Markets | Oppenheimer & Co., Baird, Madison Williams & Co., Morgan Keegan, Wunderlich Securities |
| Tranzyme | TZYM | $4.00-$4.00 | 13.5 million | 4/4 | Citi | BMO Capital Markets, Canaccord Genuity, Stifel Nicolaus Weisel |
They are a limited partnership formed by CVR Energy to own, operate and grow their nitrogen fertilizer business.
Morgan Stanley, Barclays Capital, Goldman Sachs
Dahlman Rose & Co., RBS, Simmons & Co., Suntrust Robinson Humphrey
IPO
They were formed by Golar LNG Limited to own floating storage and regasification units and LNG carriers
Citi, BofA Merrill Lynch, Morgan Stanley
Raymond James, RBC Capital Markets, Wells Fargo Securities, BNP Paribas, DnB Markets, Evercore Partners
IPO
Stifel Nicholaus Weisel, Needham & Company
Craig-Hallum Capital, Merriman Capital
Secondary
They are a Delaware statutory trust formed in December 2010 to own (a) royalty interests to be conveyed to the trust by SandRidge in 37 horizontal wells producing from the Mississippian formation in Alfalfa, Garfield, Grant, Major and Woods counties in Oklahoma, and (b) royalty interests in 123 horizontal development wells to be drilled in the Mississippian formation.
Raymond James, Morgan Stanley, Wells Fargo Securities, RBC Capital Markets
Oppenheimer & Co., Baird, Madison Williams & Co., Morgan Keegan, Wunderlich Securities
IPO
They are a clinical-stage biotech developing small molecule therapeutics to treat gastrointestinal disorders.
Citi
BMO Capital Markets, Canaccord Genuity, Stifel Nicolaus Weisel
IPO
"Recently" filed IPO's and Secondaries: